Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Patricia K. Latham |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism / Raymond F. Anton en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)
[artículo]
Título : Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism Tipo de documento: texto impreso Autores: Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia K. Latham, Autor Fecha de publicación: 2023 Artículo en la página: pp. 72-77 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Naltrexona, Antagonistas narcóticos. Resumen: Naltrexone, an opiate antagonist medication, has been reported to be efficacious in the treatment of alcohol dependence when added to psychosocial treatments. Although the within-treatment efficacy of naltrexone has received primary attention, there has been little published on the outcome of individuals once the medication is discontinued. Link: ./index.php?lvl=notice_display&id=31140
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 72-77[artículo] Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism [texto impreso] / Raymond F. Anton, Autor ; Darlene H. Moak, Autor ; Patricia K. Latham, Autor . - 2023 . - pp. 72-77.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 72-77
Palabras clave: Alcoholismo, Terapia de conducta cognitiva, Terapia de modalidad combinada, Naltrexona, Antagonistas narcóticos. Resumen: Naltrexone, an opiate antagonist medication, has been reported to be efficacious in the treatment of alcohol dependence when added to psychosocial treatments. Although the within-treatment efficacy of naltrexone has received primary attention, there has been little published on the outcome of individuals once the medication is discontinued. Link: ./index.php?lvl=notice_display&id=31140